3680
Z. Wang et al.
PAPER
MS (EI, 70 eV): m/z (%) = 317 (100), 190 (8), 176 (99), 115 (79),
102 (51).
1H NMR (400 MHz, CDCl3): d = 7.65 (d, J = 16.0 Hz, 1 H), 7.19
(dd, J1 = 8.0 Hz, J2 = 1.6 Hz, 1 H), 7.65 (d, J = 1.6 Hz, 1 H), 7.09
(d, J = 8.0 Hz, 1 H), 6.82 (d, J = 16.0 Hz, 1 H), 4.02 (s, 2 H), 3.89
(s, 3 H), 2.34 (s, 3 H).
13C NMR (100 MHz, CDCl3): d = 192.0, 168.7, 151.3, 144.3, 141.8,
132.8, 123.3, 122.2, 121.7, 111.5, 55.9, 20.6, 4.9.
(E)-4-(9-Anthryl)-1-iodobut-3-en-2-one (10i)
IR (KBr): 1674, 1600, 1405, 1263, 1194, 1040, 994, 889, 841, 782,
737 cm–1.
1H NMR (400 MHz, CDCl3): d = 8.65 (d, J = 16.0 Hz, 1 H), 8.44 (s,
1 H), 8.22 (d, J = 8.4 Hz, 2 H), 8.01 (d, J = 8.4 Hz, 2 H), 7.54–7.47
(m, 4 H), 6.85 (d, J = 16.0 Hz, 1 H), 4.11 (s, 2 H).
MS (EI, 70 eV): m/z (%) = 360 (5), 318 (100), 191 (88), 177 (95),
159 (84), 145 (37), 131 (47), 103 (20), 91 (8).
13C NMR (100 MHz, CDCl3): d = 191.6, 142.1, 131.0, 130.9, 129.4,
128.8, 128.6, 126.5, 125.3, 124.8, 5.2.
Ethyl (E)-2-Benzylidene-4-iodo-3-oxobutanoate (10o)
IR (KBr): 3444, 1717, 1697, 1618, 1257, 1198, 1025, 692 cm–1.
MS (EI, 70 eV): m/z (%) = 372 (14), 245 (41), 202 (100).
1H NMR (400 MHz, CDCl3): d = 7.82 (s, 1 H), 7.42–7.40 (m, 5 H),
4.33 (q, J = 7.2 Hz, 2 H), 4.10 (s, 2 H), 1.36 (t, J = 7.2 Hz, 3 H).
(E)-4-(4-Hydroxy-3-methoxyphenyl)-1-iodobut-3-en-2-one
13C NMR (100 MHz, CDCl3): d = 195.8, 163.9, 144.0, 132.5, 130.9,
(10j)14
130.1, 129.7, 129.0, 128.7, 61.8, 14.1, 8.7.
IR (KBr): 3393, 1674, 1583, 1510, 1426, 1271, 1159, 1044, 1028,
978, 845, 810 cm–1.
MS (EI, 70 eV): m/z (%) = 344 (11), 299 (100), 217 (99), 115 (41),
102 (42), 76 (19).
1H NMR (600 MHz, CDCl3): d = 7.62 (d, J = 15.6 Hz, 1 H), 7.15
(dd, J1 = 8.4 Hz, J2 = 1.8 Hz, 1 H), 7.07 (d, J = 1.8 Hz, 1 H), 6.95
(d, J = 8.4 Hz, 1 H), 6.73 (d, J = 15.6 Hz, 1 H), 6.01 (s, 1 H, OH),
4.01 (s, 2 H), 3.95 (s, 3 H).
13C NMR (100 MHz, CDCl3): d = 192.4, 148.7, 146.7, 145.4, 126.2,
123.9, 119.6, 114.8, 109.7, 55.9, 4.9.
(Z)-2-Benzylidene-4-iodo-1-phenylbutane-1,3-dione (10p)
IR (KBr): 3444, 1668, 1637, 1617, 1594, 1573, 1233, 1258, 1211,
915, 782, 769 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.99 (s, 1 H), 7.95 (d, J = 8.0 Hz,
2 H), 7.54–7.51 (m, 1 H), 7.41–7.21 (m, 7 H), 4.20 (s, 2 H).
MS (EI, 70 eV): m/z (%) = 318 (100), 191 (2), 141 (23), 103 (33),
91 (16), 77 (11).
13C NMR (100 MHz, CDCl3): d = 196.7, 190.7, 143.5, 135.7, 135.6,
134.1, 132.4, 130.8, 130.4, 129.2, 128.7, 128.6, 2.3.
MS (EI, 70 eV): m/z (%) = 376 (5), 249 (89), 105 (100), 77 (48).
(3E,5E)-1-Iodo-6-phenylhexa-3,5-dien-2-one (10k)
IR (KBr): 3424, 1671, 1583, 1413, 1006, 753, 688, 642 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.50–7.33 (m, 6 H), 7.03–6.88 (m,
2 H), 6.43 (d, J = 15.6 Hz, 1 H), 3.95 (s, 2 H).
13C NMR (100 MHz, CDCl3): d = 192.3, 145.0, 142.7, 135.7, 129.5,
128.8, 127.4, 126.1, 125.4, 4.8.
Acknowledgment
This work was supported by the National Natural Science Founda-
tion of China (Nos. 20672042 and 20872042) and the Graduate’s
Innovation Fund of Central China Normal University (2007).
MS (EI, 70 eV): m/z (%) = 298 (17), 171 (100), 157 (32), 128 (88),
102 (7), 77 (5).
References
(E)-4-Iodo-1-phenylpent-1-en-3-one (10l)
(1) (a) Kusama, H.; Onizawa, Y.; Iwasawa, N. J. Am. Chem.
Soc. 2006, 128, 16500. (b) Babu, K. S.; Li, X.-C.; Jacob, M.
R.; Zhang, Q.; Khan, S. I.; Ferreira, D.; Clark, A. M. J. Med.
Chem. 2006, 49, 7877. (c) Li, X.-C.; Ferreira, D.; Jacob, M.
R.; Zhang, Q.; Khan, S. I.; Elsohly, H. N.; Nagle, D. G.;
Smillie, T. J.; Khan, I. A.; Walker, L. A.; Clark, A. M. J. Am.
Chem. Soc. 2004, 126, 6872.
(2) Bora, U.; Saikia, A.; Boruah, R. C. Org. Lett. 2003, 5, 435.
(3) (a) Parker, D. L. Jr.; Ratcliffe, R. W.; Wilkening, R. R.;
Wildonger, K. J. WO 2001,082,923, 2001. (b) Rohrer, S. P.
WO 2005,099,704, 2005. (c) Tsukano, C.; Siegel, D. R.;
Danishefsky, S. J. Angew. Chem. Int. Ed. 2007, 46, 8840.
(4) (a) Southwick, P. L.; Pursglove, L. A.; Numerof, P. J. Am.
Chem. Soc. 1950, 72, 1600. (b) Southwick, P. L.; Pursglove,
L. A.; Numerof, P. J. Am. Chem. Soc. 1950, 72, 1604.
(c) Cristau, H.-J.; Torreilles, E.; Morand, P.; Christol, H.
Phosphorus, Sulfur Silicon Relat. Elem. 1985, 25, 357.
(5) (a) Okamoto, T.; Kakinami, T.; Nishimura, T.; Hermawan,
I.; Kajigaeshi, S. Bull. Chem. Soc. Jpn. 1992, 65, 1731.
(b) Burluenga, J.; Marco-Arias, M.; González-Bobes, F.;
Ballesteros, A.; González, J. M. Chem. Commun. 2004,
2616.
IR (KBr): 3421 (s), 1680 (s), 1610 (s), 1572 (s), 1444 (s), 1092 (s),
1040 (s), 975 (s), 761 (s), 709 (s), 683 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.73 (d, J = 16.0 Hz, 1 H), 7.60–
7.56 (m, 2 H), 7.42–7.40 (m, 3 H), 6.93 (d, J = 16.0 Hz, 1 H), 4.87
(q, J = 6.8 Hz, 1 H), 2.00 (d, J = 6.8 Hz, 3 H).
13C NMR (100 MHz, CDCl3): d = 193.7, 144.1, 134.0, 130.7, 128.8,
128.5, 121.8, 24.5, 21.5.
MS (EI, 70 eV): m/z (%) = 286 (12), 159 (10), 131 (76), 127 (39),
103 (47), 91 (30), 77 (89), 51 (100).
(E)-4-[4-(Benzyloxy)-3-methoxyphenyl]-1-iodobut-3-en-2-one
(10m)
IR (KBr): 1667, 1616, 1591, 1512, 1276, 1256, 1138, 993, 917, 867
cm–1.
1H NMR (400 MHz, CDCl3): d = 7.62 (d, J = 16.0 Hz, 1 H), 7.44–
7.32 (m, 5 H), 7.11–7.09 (m, 2 H), 6.89 (d, J = 8.8 Hz, 1 H), 6.73
(d, J = 16.0 Hz, 1 H), 5.22 (s, 2 H), 4.01 (s, 2 H), 3.95 (s, 3 H).
13C NMR (100 MHz, CDCl3): d = 192.1, 150.7, 149.5, 145.0, 136.2,
128.5, 128.0, 127.1, 127.0, 123.3, 120.0, 113.0, 110.2, 70.6, 55.9,
5.0.
(6) (a) Higgins, S. D.; Thomas, C. B. J. Chem. Soc., Perkin
Trans. 1 1982, 235. (b) Bekaert, A.; Barberan, O.; Gervais,
M.; Brion, J. D. Tetrahedron Lett. 2000, 41, 2903.
(c) Le Bras, G.; Provot, O.; Bekaert, A.; Peyrat, J.-F.; Alami,
M.; Brion, J.-D. Synthesis 2006, 1537.
MS (EI, 70 eV): m/z (%) = 408 (3), 365 (2), 281 (20), 91 (100).
(E)-4-(4-Acetoxy-3-methoxyphenyl)-1-iodobut-3-en-2-one
(10n)
IR (KBr): 1748, 1668, 1645, 1509, 1226, 1201, 1160, 1121, 1033,
(7) Horiuchi, C. A.; Kiji, S. Bull. Chem. Soc. Jpn. 1997, 70, 421.
985, 914, 864 cm–1.
Synthesis 2008, No. 22, 3675–3681 © Thieme Stuttgart · New York